4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-23-021133
Chief Scientific Officer sold 2,696 shares at an average $0.64 ($1,739)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loose Christopher R. · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-19 | Sale : show line 1 in the form 10b5-1 | −1,335 | $0.65 | $868 | 193,218 | D |
| 2023-07-20 | Sale : show line 2 in the form 10b5-1 | −1,361 | $0.64 | $871 | 191,857 | D |
| Open-market sales · 2,696 sh · avg $0.64 · $1,739 | ||||||
Loading xslF345X05/form4.xml…